DekaBank Deutsche Girozentrale - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$65
-100.0%
8,448
-83.2%
0.00%
-100.0%
Q3 2022$362,000
-27.7%
50,2000.0%0.00%0.0%
Q2 2022$501,000
-19.5%
50,2000.0%0.00%
-50.0%
Q1 2022$622,000
-39.2%
50,200
+10.1%
0.00%0.0%
Q4 2021$1,023,000
-2.1%
45,6000.0%0.00%
-33.3%
Q3 2021$1,045,000
+78.3%
45,6000.0%0.00%
+50.0%
Q2 2021$586,000
+3.7%
45,6000.0%0.00%0.0%
Q1 2021$565,000
-9.3%
45,6000.0%0.00%0.0%
Q4 2020$623,000
+20.3%
45,600
+23.6%
0.00%0.0%
Q3 2020$518,00036,9000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders